The AI Chronicles #6: 2024 Outlook for Life Sciences GenAI, Drug Prices, and Regulatory Challenges
Reading Time: 4 mins We are back with the 6th edition of The AI Chronicles Series. This blog discusses the 2024 Outlook for Life Sciences GenAI, Drug Prices, Regulatory Changes and Challenges, Market Conditions, and Argument- Regulatory Oversight. Do […]